Pharma Mirror Magazine

Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab

January 26, 2022

Waltham, Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced positive topline results from

Pharmaceutical News

Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories Limited

January 22, 2022

Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a

Pharmaceutical News

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

January 18, 2022

BARCELONA, Spain, a global biopharmaceutical company focused on skin health, and IRB Barcelona (the Institute for Research in Biomedicine), an independent,

Pharmaceutical News

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

January 18, 2022

ADELAIDE, Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from

Pharmaceutical News

Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing

January 17, 2022

January 17, 2022 (Davis, CA) – Botanical Solution Inc. (BSI), innovator of sustainable, consistent, and cost-effective Advanced Botanical Materials for

Pharmaceutical News

2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health: CPhI Worldwide Report

January 15, 2022

Amsterdam, CPhI Worldwide – the world’s largest pharma event, which will be hosted at the Frankfurt Messe (1-3 November, 2022) – releases the final

MORE NEWS

Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab

Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories Limited

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing

2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health: CPhI Worldwide Report